Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biologics

PUBLISHER: Grand View Research | PRODUCT CODE: 1609967

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1609967

Plasma Fractionation Market Size, Share & Trends Analysis Report By Product (Immunoglobulins, Coagulation Factors), By Method (Chromatography, Centrifugation), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Plasma Fractionation Market Growth & Trends:

The global plasma fractionation market size is estimated to reach USD 58.24 billion by 2030, registering to grow at a CAGR of 8.5% from 2025 to 2030 according to a new report by Grand View Research, Inc. The major factors driving the market growth are the rising prevalence of respiratory illnesses globally, blood-related diseases, and an aging population that is prone to a variety of rare disorders. These are the main drivers of market expansion. In addition, the rise in the prevalence of rare disorders that call for plasma therapy or derivatives also supplemented the market growth.

The global market is also expanding due to the increased use of immunoglobulins as well as alpha-1-antitrypsin in various areas of research around the world. Another important factor for the expansion of the market is the rise in blood collection facilities globally. For instance, as per the WHO, as of May 2022, over 118 million blood donations were collected across the globe, thus increasing the plasma supply gradually. Additionally, supportive government initiatives to raise public awareness about the usage of plasma-derived products also serve as a major driver of the global market's expansion.

Blood plasma transfusions are one of the cutting-edge treatments for COVID-19 infection. For instance, in August 2020, the US Food and Drug Administration (USFDA) granted the convalescent plasma treatment of COVID-19 an emergency use authorization (EUA). Additionally, in February 2021, it published an amended directive for the plasma EUA for COVID-19. As a result, the usage of plasma fractionation technologies is projected to increase during the COVID-19 pandemic.

The growing demand for personalized medications has increased R&D spending, and technological advancements in plasma components such as immune serum globulin, which have advantages such as higher yield, lower cost, and faster throughput, are driving market growth. On the other hand, immunoglobulins generated from plasma are being employed more frequently for a variety of clinical conditions, including autoimmune and inflammatory illnesses. Therapies including Ceruloplasmin, IgA, and Plasmin have received significant funding from the plasma fractionation sector. Additionally, the industry will receive a boost from booming investments in innovation and technology developments that result in efficient and affordable methods for fractionating proteins. thus, propelling the market's growth.

For companies operating market-related businesses, the market offers a lot of opportunities. In addition, the global and regional market participants are actively implementing organic and inorganic development strategies as a result of the market's favorable expansion. As a result, it is anticipated that the market will draw more notable investments during the forecast period. For instance, in January 2022, the eighth plasma collection facility in the Czech Republic was opened by Biotest AG. The national public health authority, SUKL, granted the company an operating license for these centers.

Plasma Fractionation Market Report Highlights:

  • The immunoglobulins segment dominated the market in terms of revenue share of 63.2% in 2024 and is anticipated to grow at the fastest CAGR of 9.1%. fueled by its widespread use in treating immune deficiencies, autoimmune diseases, and neurological disorders.
  • The chromatography segment dominated the market and accounted for a 33.7% share in 2024. The utilization of industrial-scale chromatographic fractionation as well as purification techniques for plasma fractionation has increased recently.
  • The neurology segment held the largest revenue share of 30.0% in 2024, driven by the increasing recognition of plasma-derived therapies for neurological disorders. Conditions such as multiple sclerosis, Guillain-Barre syndrome, and chronic inflammatory demyelinating polyneuropathy are increasingly being treated with therapies like intravenous immunoglobulin (IVIg) and plasmapheresis.
  • The hospitals and clinics dominated the market with the largest revenue share of 53.4% in 2024 and are expected to grow at the fastest CAGR of 9.0% over the forecast period. This is driven by the increasing demand for plasma-derived therapies in various medical applications.
Show more
Product Code: GVR-4-68039-962-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Method Segment
    • 1.2.3. Application Segment
    • 1.2.4. End use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Plasma Fractionation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing Demand For Advanced Treatment Options To Boost Market Growth
      • 3.2.1.2. Growing Use Of Immunoglobulins In Various Therapeutic Areas
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent Regulatory Policies
  • 3.3. Plasma Fractionation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Plasma Fractionation Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Plasma Fractionation Market Product Movement Analysis
  • 4.3. Global Plasma Fractionation Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Billion)
  • 4.4. Albumin
    • 4.4.1. Albumin market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Immunoglobulins
    • 4.5.1. Immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2. Intravenous immunoglobulins
      • 4.5.2.1. Intravenous immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3. Subcutaneous immunoglobulins
      • 4.5.3.1. Subcutaneous immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.4. Other immunoglobulins
      • 4.5.4.1. Other immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. Coagulation Factors
    • 4.6.1. Coagulation factors market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.2. Factor VIII
      • 4.6.2.1. Factor VIII market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.3. Factor IX
      • 4.6.3.1. Factor IX market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.4. VON WILLEBRAND factor
      • 4.6.4.1. VON WILLEBRAND factor market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.5. Prothrombin complex concentrates
      • 4.6.5.1. Prothrombin complex concentrates market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.6. Fibrinogen concentrates
      • 4.6.6.1. Fibrinogen concentrates market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.7. Others
      • 4.6.7.1. Others factor market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Protease inhibitors
    • 4.7.1. Protease inhibitors market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Plasma Fractionation Market: Method Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Plasma Fractionation Market Method Movement Analysis
  • 5.3. Global Plasma Fractionation Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Billion)
  • 5.4. Centrifugation
    • 5.4.1. Centrifugation market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Depth Filtration
    • 5.5.1. Depth filtration market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Chromatography
    • 5.6.1. Chromatography market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Plasma Fractionation Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Plasma Fractionation Market Application Movement Analysis
  • 6.3. Global Plasma Fractionation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 6.4. Neurology
    • 6.4.1. Neurology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Hematology
    • 6.5.1. Hematology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.6. Oncology
    • 6.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.7. Immunology
    • 6.7.1. Immunology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.8. Pulmonology
    • 6.8.1. Pulmonology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.9. Others
    • 6.9.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Plasma Fractionation Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Plasma Fractionation Market End-use Movement Analysis
  • 7.3. Global Plasma Fractionation Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Billion)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5. Clinical Research
    • 7.5.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 8. Plasma Fractionation Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Competitive scenario
      • 8.4.1.3. Regulatory framework
      • 8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.6. Denmark
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.8. Norway
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Regulatory framework
      • 8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Competitive scenario
      • 8.8.1.3. Regulatory framework
      • 8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Grifols S.A.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. CSL Limited
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Takeda Pharmaceutical Company Limited
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Octapharma AG
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Kedrion S.p.A
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. LFB S.A.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Biotest AG
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Sanquin
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Bio Products Laboratory Ltd.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Intas Pharmaceuticals Ltd
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
Show more
Product Code: GVR-4-68039-962-8

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global plasma fractionation market, by region, 2018 - 2030 (USD Billion)
  • Table 3 Global plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 4 Global plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 5 Global plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 6 Global plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7 North America plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 8 North America plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 9 North America plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 10 North America plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 11 North America plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 12 U.S. plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 13 U.S. plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 14 U.S. plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 15 U.S. plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 Canada plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 17 Canada plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 18 Canada plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 19 Canada plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20 Mexico plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 21 Mexico plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 22 Mexico plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 23 Mexico plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 Europe plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 25 Europe plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 26 Europe plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 27 Europe plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 28 Europe plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 29 UK plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 30 UK plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 31 UK plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 32 UK plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Germany plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 34 Germany plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 35 Germany plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 36 Germany plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 France plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 38 France plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 39 France plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 40 France plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 Italy plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 42 Italy plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 43 Italy plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 44 Italy plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Spain plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 46 Spain plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 47 Spain plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 48 Spain plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 49 Denmark plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 50 Denmark plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 51 Denmark plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 52 Denmark plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 53 Sweden plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 54 Sweden plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 55 Sweden plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 56 Sweden plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 57 Norway plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 58 Norway plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 59 Norway plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 60 Norway plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 61 Asia Pacific plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 62 Asia Pacific plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 63 Asia Pacific plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 64 Asia Pacific plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 65 Asia Pacific plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 66 Japan plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 67 Japan plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 68 Japan plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 69 Japan plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 70 China plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 71 China plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 72 China plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 73 China plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 74 India plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 75 India plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 76 India plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 77 India plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 78 Australia plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 79 Australia plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 80 Australia plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 81 Australia plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 82 South Korea plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 83 South Korea plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 84 South Korea plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 85 South Korea plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 86 Thailand plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 87 Thailand plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 88 Thailand plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 89 Thailand plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 90 Latin America plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 91 Latin America plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 92 Latin America plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 93 Latin America plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 94 Latin America plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 95 Brazil plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 96 Brazil plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 97 Brazil plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 98 Brazil plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 99 Argentina plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 100 Argentina plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 101 Argentina plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 102 Argentina plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 103 MEA plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 104 MEA plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 105 MEA plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 106 MEA plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 107 MEA plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 108 South Africa plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 109 South Africa plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 110 South Africa plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 111 South Africa plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 112 Saudi Arabia plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 113 Saudi Arabia plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 114 Saudi Arabia plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 115 Saudi Arabia plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 116 UAE plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 117 UAE plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 118 UAE plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 119 UAE plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 120 Kuwait plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 121 Kuwait plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 122 Kuwait plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 123 Kuwait plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Plasma fractionation market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Plasma fractionation market: Product outlook key takeaways
  • Fig. 20 Plasma fractionation market: Product movement analysis
  • Fig. 21 Albumin market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Intravenous immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Subcutaneous immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Other immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Coagulation Factors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Factor VIII market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Factor IX market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 VON WILLEBRAND factor market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Prothrombin complex concentrates market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Fibrinogen concentrates market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Protease inhibitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Plasma fractionation market: Method outlook key takeaways
  • Fig. 36 Plasma fractionation market: Method movement analysis
  • Fig. 37 Centrifugation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Depth Filtration market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Chromatography market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Plasma fractionation market: Application outlook key takeaways
  • Fig. 42 Plasma fractionation market: Application movement analysis
  • Fig. 43 Neurology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Hematology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Oncology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Immunology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Pulmonology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Plasma fractionation market: End-use outlook key takeaways
  • Fig. 50 Plasma fractionation market: End-use movement analysis
  • Fig. 51 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Clinical research market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Regional marketplace outlook, 2024 & 2030 (USD Billion)
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 North America plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 Key country dynamics
  • Fig. 58 U.S. plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Key country dynamics
  • Fig. 60 Canada plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Key country dynamics
  • Fig. 62 Mexico plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Europe plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 Key country dynamics
  • Fig. 65 UK plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Key country dynamics
  • Fig. 67 Germany plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 Key country dynamics
  • Fig. 69 France plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Key country dynamics
  • Fig. 71 Spain plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Key country dynamics
  • Fig. 73 Italy plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 Key country dynamics
  • Fig. 75 Denmark plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 Key country dynamics
  • Fig. 77 Sweden plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 78 Key country dynamics
  • Fig. 79 Norway plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 80 Asia Pacific plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 81 Key country dynamics
  • Fig. 82 Japan plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 83 Key country dynamics
  • Fig. 84 China plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 85 Key country dynamics
  • Fig. 86 India plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 87 Key country dynamics
  • Fig. 88 Australia plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Korea plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 91 Key country dynamics
  • Fig. 92 Thailand plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 93 Key country dynamics
  • Fig. 94 Market participant categorization
  • Fig. 95 Plasma fractionation market position analysis, 2024
  • Fig. 96 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!